DORAMAPIMOD |
DORAMAPIMOD : Inhibitor of MAPK14
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MAPK14 |
|
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
The SafetyScreen44™ panel has been measured (@10 mM) for BIRB 796, and for 0/44 proteins >70% inhibi ...
Potency Cellular
In Vitro
MAPK14
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm030121k
In Vivo Validations
Mouse
Dose: 1 mg/Kg (IV), 10 mg/Kg (PO)
Route of delivery:
Intravenous, Oral
Systemic clearance:
0.33 mL/min/Kg IV
Cmax:
27000 ng/mL PO
Tmax:
1.0 h PO
Bioavailability:
23% PO
Volume of Distribution at Steady-State:
0.07 L/Kg IV
DOI Reference: 10.1021/jm030121k
Rat
Dose: 1 mg/Kg (IV), 10 mg/Kg (PO)
Route of delivery:
Intravenous, Oral
Systemic clearance:
4% QH
Cmax:
5500 ng/ml PO
Bioavailability:
75% PO
Volume of Distribution at Steady-State:
0.2 L/Kg IV
DOI Reference: 10.1021/jm030121k
Chemical Information
| Molecular Formula | C31H37N5O3 |
| SMILEs | Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1 |
| InChI | InChI=1S/C31H37N5O3/c1-22-9-11-23(12-10-22)36-29(21-28(34-36)31(2,3)4)33-30(37)32-26-13-14-27(25-8-6-5-7-24(25)26)39-20-17-35-15-18-38-19-16-35/h5-14,21H,15-20H2,1-4H3,(H2,32,33,37) |
| Molecular weight | 527.29 Da |
| AlogP | 5.98642 |
| HBond acceptors | 8 |
| HBond donors | 2 |
| Atoms | 76 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.